These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 28598856)

  • 1. Glucocerebrosidase Mutations in Parkinson Disease.
    O'Regan G; deSouza RM; Balestrino R; Schapira AH
    J Parkinsons Dis; 2017; 7(3):411-422. PubMed ID: 28598856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocerebrosidase and Parkinson Disease: Molecular, Clinical, and Therapeutic Implications.
    Balestrino R; Schapira AHV
    Neuroscientist; 2018 Oct; 24(5):540-559. PubMed ID: 29400127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocerebrosidase and Parkinson disease: Recent advances.
    Schapira AH
    Mol Cell Neurosci; 2015 May; 66(Pt A):37-42. PubMed ID: 25802027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson's disease and their targeted therapeutic approaches: a comprehensive review.
    Behl T; Kaur G; Fratila O; Buhas C; Judea-Pusta CT; Negrut N; Bustea C; Bungau S
    Transl Neurodegener; 2021 Jan; 10(1):4. PubMed ID: 33446243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [GBA mutations and Parkinson's disease].
    Wang DX; Xie JX; Song N
    Sheng Li Xue Bao; 2018 Jun; 70(3):294-300. PubMed ID: 29926071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between glucocerebrosidase mutations and Parkinson disease.
    Migdalska-Richards A; Schapira AH
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):77-90. PubMed ID: 26860875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucosylsphingosine Promotes α-Synuclein Pathology in Mutant GBA-Associated Parkinson's Disease.
    Taguchi YV; Liu J; Ruan J; Pacheco J; Zhang X; Abbasi J; Keutzer J; Mistry PK; Chandra SS
    J Neurosci; 2017 Oct; 37(40):9617-9631. PubMed ID: 28847804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocerebrosidase mutations and the pathogenesis of Parkinson disease.
    Beavan MS; Schapira AH
    Ann Med; 2013 Dec; 45(8):511-21. PubMed ID: 24219755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation.
    Galvagnion C; Marlet FR; Cerri S; Schapira AHV; Blandini F; Di Monte DA
    Brain; 2022 Apr; 145(3):1038-1051. PubMed ID: 35362022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in GBA-associated Parkinson's disease--Pathology, presentation and therapies.
    Barkhuizen M; Anderson DG; Grobler AF
    Neurochem Int; 2016 Feb; 93():6-25. PubMed ID: 26743617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
    Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
    J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Smith L; Schapira AHV
    Cells; 2022 Apr; 11(8):. PubMed ID: 35455941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocerebrosidase mutations: A paradigm for neurodegeneration pathways.
    Vieira SRL; Schapira AHV
    Free Radic Biol Med; 2021 Nov; 175():42-55. PubMed ID: 34450264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological effects of glucocerebrosidase gene mutations.
    Mullin S; Hughes D; Mehta A; Schapira AHV
    Eur J Neurol; 2019 Mar; 26(3):388-e29. PubMed ID: 30315684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers.
    Anheim M; Elbaz A; Lesage S; Durr A; Condroyer C; Viallet F; Pollak P; Bonaïti B; Bonaïti-Pellié C; Brice A;
    Neurology; 2012 Feb; 78(6):417-20. PubMed ID: 22282650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders.
    Velayati A; Yu WH; Sidransky E
    Curr Neurol Neurosci Rep; 2010 May; 10(3):190-8. PubMed ID: 20425034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease.
    Pchelina S; Emelyanov A; Baydakova G; Andoskin P; Senkevich K; Nikolaev M; Miliukhina I; Yakimovskii A; Timofeeva A; Fedotova E; Abramycheva N; Usenko T; Kulabukhova D; Lavrinova A; Kopytova A; Garaeva L; Nuzhnyi E; Illarioshkin S; Zakharova E
    Neurosci Lett; 2017 Jan; 636():70-76. PubMed ID: 27780739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
    Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
    Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
    Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
    Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of mutations in the glucocerebrosidase gene with Parkinson disease in a Korean population.
    Choi JM; Kim WC; Lyoo CH; Kang SY; Lee PH; Baik JS; Koh SB; Ma HI; Sohn YH; Lee MS; Kim YJ
    Neurosci Lett; 2012 Apr; 514(1):12-5. PubMed ID: 22387070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.